MRI-based clinical-radiomics-habitat model for predicting prognosis of hepatocellular carcinoma patients treated with HAIC

Puntos clave

• The model predicts early treatment response in hepatocellular carcinoma patients, improving decision-making.
• Key evidence from the model indicates significant prognostic value in personalized treatment settings.
• Assessment using a multiparametric MRI-based approach highlights the complexity of tumor behavior.
• Implications suggest that personalized treatment may enhance patient outcomes in hepatocellular carcinoma cases.